Inhibitors of c-Jun N-terminal kinases—JuNK no more?
- 11 October 2007
- journal article
- review article
- Published by Elsevier BV in Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics
- Vol. 1784 (1), 76-93
- https://doi.org/10.1016/j.bbapap.2007.09.013
Abstract
No abstract availableKeywords
This publication has 116 references indexed in Scilit:
- Critical role of c-jun (NH2) terminal kinase in paracetamol- induced acute liver failureGut, 2007
- Novel Strategy for Treatment of Viral Central Nervous System Infection by Using a Cell-Permeating Inhibitor of c-Jun N-Terminal KinaseJournal of Virology, 2007
- Mitogen-Activated Protein Kinases Activate the Nuclear Localization Sequence of Human Papillomavirus Type 11 E1 DNA Helicase To Promote Efficient Nuclear ImportJournal of Virology, 2007
- c-Jun N-terminal kinase inhibitor SP600125 modulates the period of mammalian circadian rhythmsNeuroscience, 2007
- Varicella-Zoster Virus Infection of Human Fibroblast Cells Activates the c-Jun N-Terminal Kinase PathwayJournal of Virology, 2007
- Uses for JNK: the Many and Varied Substrates of the c-Jun N-Terminal KinasesMicrobiology and Molecular Biology Reviews, 2006
- Rotavirus Activates JNK and p38 Signaling Pathways in Intestinal Cells, Leading to AP-1-Driven Transcriptional Responses and Enhanced Virus ReplicationJournal of Virology, 2006
- Functional in vivo interactions between JNK1 and JNK2 isoforms in obesity and insulin resistanceProceedings of the National Academy of Sciences of the United States of America, 2006
- Structural basis for the selective inhibition of JNK1 by the scaffolding protein JIP1 and SP600125The EMBO Journal, 2004
- Cell Death: Critical Control PointsCell, 2004